Skip to main content

Table 1 Characteristics of people with epilepsy reported by the CAAE board members during the survey

From: Management of people with epilepsy during the COVID-19 pandemic: a national survey among epileptologists in China

Variates  All COVID-19 epidemic severity areas  
Low-risk area Moderate-risk area High-risk area P value
Number of surveyed responders, n 130 38 89 3  
Average number of patients with consultation reported per responder, median (range) 155 (6, 1 400) 115 (18, 1 400) 179 (6, 1 210) 200 (150, 766)  
Telephone- or internet-based consultationa, n (%) 81 (32.3) 93 (38.8) 67 (26.9) 329 (88.4) < 0.001
Patients with regular case reviewa, n (%) 172 (68.6) 159 (66.5) 171 (68.2) 349 (93.9) < 0.001
Patients with increased episodes of seizuresb, n (%) 26 (15.4) 26 (16.3) 25 (14.9) 62 (17.7) 0.006
Patients with status epilepticusb, n (%) 2 (0.9) 1 (0.8) 2 (1.0) 3 (0.9) 0.184
Patients with aggravation of psychological disordersb, n (%) 32 (18.8) 42 (26.2) 26 (15.1) 106 (30.2) < 0.001
Patients who did not come for regular case review albeit they shouldc, n (%) 460 (73.3) 724 (82.0) 345 (67.6) 527 (60.2) < 0.001
Patients who were unable to obtain ASMsa, n (%) 88 (35.0) 94 (39.4) 78 (31.1) 287 (77.2) < 0.001
  1. ASMs antiseizure medications
  2. aAmong all the patients with consultation; bAmong patients with regular case review; cAmong all patients who should come for regular case review; (%), the average number of patients reported per responder (%)